The Keystone Symposium ‘MicroRNAs and Noncoding RNAs in Cancer’, Keystone, CO, USA, 7–12 June 2015
Since the discovery of RNAi, great efforts have been undertaken to unleash the potential biomedical applicability of small noncoding RNAs, mainly miRNAs, involving their use as biomarkers for personalized diagnostics or their usability as active agents or therapy targets. The research’s focus on the noncoding RNA world is now slowly moving from a phase of basic discoveries into a new phase, where every single molecule out of many hundreds of cataloged noncoding RNAs becomes dissected in order to investigate these molecules’ biomedical relevance. In addition, RNA classes neglected before, such as long noncoding RNAs or circular RNAs attract more attention. Numerous timely results and hypotheses were presented at the 2015 Keystone Symposium ‘MicroRNAs and Noncoding RNAs in Cancer’.
Acknowledgements
The authors would like to thank all oral and poster presenters not mentioned above, who nevertheless contributed to the success of the meeting in an indispensable way.
Financial & competing interests disclosure
KO Hensel and J Postberg were kindly supported by the Deutscher Akademischer Austauschdienst (DAAD). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.